Abbott Laboratories (NYSE: ABT) last traded at $102.97, up 0.35% on the session. The quote above updates while this page is open; the figures below are drawn from Abbott Laboratories’s own filings and are restated only when a new one is published.
Abbott Laboratories trades on NYSE under the ticker ABT. It is classified in the Healthcare sector, Medical Devices industry. Its market capitalisation is $179.35 billion.
Healthcare sectorMedical DevicesListed on NYSE
Valuation measures for Abbott Laboratories, derived from the latest quote and its most recent SEC filing.
| Market cap | $179.35B |
|---|---|
| Enterprise value | $230.28B |
| P/E ratio | 28.84 |
| Price / sales | 3.97 |
| Price / book | 3.45 |
|---|
| Beta | 0.04 |
|---|
Trailing-twelve-month figures tagged in Abbott Laboratories's XBRL filings with the SEC.
| Revenue (TTM) | $45.13B |
|---|---|
| Net income (TTM) | $6.28B |
| EPS (TTM) | $3.57 |
| Gross margin | 56.26% |
| Operating margin | 17.07% |
| Return on equity | 12.06% |
| Cash | $6.80B |
Range and volume for ABT over the past 52 weeks.
| 52-week high | $132.03 |
|---|---|
| 52-week low | $81.97 |
| Volume | 7.28M |
| Average volume | 9.50M |
| Previous close | $102.61 |
Dividend history for Abbott Laboratories over the trailing twelve months.
| Dividend yield | 2.37% |
|---|---|
| Dividend per share (TTM) | $2.44 |
| Payout ratio | 68.35% |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Abbott Laboratories with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ABT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.